Stockreport

All You Need to Know About Rapport Therapeutics, Inc. (RAPP) Rating Upgrade to Buy [Yahoo! Finance]

Rapport Therapeutics, Inc.  (RAPP) 
PDF upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. [Read more]